Stephen is an associate in the firm’s Corporate practice, resident in the Berwyn office. Stephen advises public and private pharmaceutical, biotechnology, and medical device companies in a broad range of matters, including mergers and acquisitions, joint ventures, divestitures, capital markets transactions, Securities Exchange Act reporting, corporate governance, licensing and collaboration transactions and other strategic transactions. He also represents venture capital and seed-stage investors, emerging companies and entrepreneurs in formations, equity and debt financings, as well as other ongoing strategic matters.

• Best Lawyers in America®: Ones to Watch, Life Sciences Practice (2026), Mergers and Acquisitions Law (2026), Venture Capital Law (2026)